Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy
For clinical application by dendritic cell (DC)-based cancer immunotherapy, a proper adjuvant system to elicit a strong anticancer immune response is needed. Here, we investigated the potential of chorismate mutase (TBCM, Rv1885c), a putative Mycobacterium tuberculosis (TB) virulence factor, as an i...
Main Authors: | Hyein Jeong, So-Young Lee, Hyejun Seo, Dong Hyun Kim, Duhyung Lee, Bum-Joon Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2021.2023340 |
Similar Items
-
A secreted form of chorismate mutase (Rv1885c) in Mycobacterium bovis BCG contributes to pathogenesis by inhibiting mitochondria-mediated apoptotic cell death of macrophages
by: Mi-Hyun Lee, et al.
Published: (2023-12-01) -
Putative Bifunctional Chorismate Mutase/Prephenate Dehydratase Contributes to the Virulence of Acidovorax citrulli
by: Minyoung Kim, et al.
Published: (2020-09-01) -
A chorismate mutase from Radopholus similis plays an essential role in pathogenicity
by: Sihua Yang, et al.
Published: (2024-03-01) -
<i>Trichoderma parareesei</i> Favors the Tolerance of Rapeseed (<i>Brassica napus</i> L.) to Salinity and Drought Due to a Chorismate Mutase
by: Jorge Poveda
Published: (2020-01-01) -
Evaluating the Diagnostic Potential of Chorismate Mutase Poly-Clonal Peptide Antibody for the <i>Acanthamoeba</i> Keratitis in an Animal Model
by: Min-Jeong Kim, et al.
Published: (2023-03-01)